EssilorLuxottica Net Income 2011-2024 | ESLOY

EssilorLuxottica annual/quarterly net income history and growth rate from 2011 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • EssilorLuxottica net income for the quarter ending June 30, 2024 was $M, a NAN% increase year-over-year.
  • EssilorLuxottica net income for the twelve months ending June 30, 2024 was $0M, a NAN% increase year-over-year.
  • EssilorLuxottica annual net income for 2023 was $2.477B, a 9.26% increase from 2022.
  • EssilorLuxottica annual net income for 2022 was $2.267B, a 30.99% increase from 2021.
  • EssilorLuxottica annual net income for 2021 was $1.731B, a 1682.64% increase from 2020.
EssilorLuxottica Annual Net Income
(Millions of US $)
2023 $2,477
2022 $2,267
2021 $1,731
2020 $97
2019 $1,206
2018 $1,284
2017 $892
2016 $900
2015 $841
2014 $1,311
2013 $858
2012 $811
2011 $722
2010 $627
EssilorLuxottica Quarterly Net Income
(Millions of US $)
2024-06-30
2023-12-31
2023-06-30
2022-12-31
2022-06-30
2021-12-31
2021-06-30
2020-12-31
2020-06-30
2019-12-31
2018-12-31
2018-06-30
2017-12-31
2017-06-30
2016-12-31
2015-12-31
2015-06-30
2014-12-31
2014-06-30
2013-12-31
2013-06-30
2012-12-31
2012-06-30
2011-12-31
2011-06-30
2010-12-31
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $115.383B $27.483B
EssilorLuxottica Soci?t? is involved in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses. The company's brand portfolio consists of Ray-Ban, Oakley, Varilux(R), Transitions(R), Sunglass Hut and LensCrafters. EssilorLuxottica Soci?t?, formerly known as Essilor International Soci?t? Anonyme, is based in Paris, France.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $196.826B 25.11
Stryker (SYK) United States $146.166B 32.94
Boston Scientific (BSX) United States $145.408B 41.81
Medtronic (MDT) Ireland $112.944B 16.78
Lonza Group Ag (LZAGY) Switzerland $43.849B 0.00
Haleon (HLN) United Kingdom $41.827B 27.18
GE HealthCare Technologies (GEHC) United States $38.715B 20.08
ResMed (RMD) United States $35.199B 28.92
Terumo (TRUMY) Japan $27.980B 0.00
Koninklijke Philips (PHG) Netherlands $24.250B 18.56
Zimmer Biomet Holdings (ZBH) United States $21.811B 13.89
Insulet (PODD) United States $19.347B 77.04
Baxter (BAX) United States $15.818B 10.29
Smith & Nephew SNATS (SNN) United Kingdom $11.057B 0.00
Bio-Rad Laboratories (BIO) United States $9.586B 32.58
BellRing Brands (BRBR) United States $9.323B 37.51
Demant (WILYY) Denmark $8.735B 0.00
Lantheus Holdings (LNTH) United States $6.360B 14.78
ICU Medical (ICUI) United States $4.012B 38.20
Prestige Consumer Healthcare (PBH) United States $3.882B 19.31
Haemonetics (HAE) United States $3.691B 18.01
Envista Holdings (NVST) United States $3.413B 25.42
Perrigo (PRGO) Ireland $3.252B 9.57
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
QuidelOrtho (QDEL) United States $2.807B 18.07
GN Store Nord (GNNDY) Denmark $2.585B 16.58
Neogen (NEOG) United States $2.508B 28.90
LeMaitre Vascular (LMAT) United States $2.227B 54.13
AtriCure (ATRC) United States $1.876B 0.00
Green Thumb Industries (GTBIF) United States $1.572B 27.52
AdaptHealth (AHCO) United States $1.416B 10.11
InMode (INMD) Israel $1.410B 8.48
BioLife Solutions (BLFS) United States $1.213B 0.00
Maravai LifeSciences Holdings (MRVI) United States $1.205B 0.00
Owens & Minor (OMI) United States $1.124B 8.78
Curaleaf Holdings (CURLF) Canada $0.981B 0.00
Phibro Animal Health (PAHC) United States $0.843B 14.87
CeriBell (CBLL) United States $0.754B 0.00
Evolus (EOLS) United States $0.666B 0.00
Capricor Therapeutics (CAPR) United States $0.623B 0.00
VAREX IMAGING (VREX) United States $0.557B 24.58
Omeros (OMER) United States $0.541B 0.00
Surmodics (SRDX) United States $0.527B 0.00
Cresco Labs (CRLBF) United States $0.434B 0.00
Verano Holdings (VRNOF) United States $0.434B 0.00
ZimVie (ZIMV) United States $0.394B 33.23
Valneva SE (VALN) France $0.355B 0.00
Quanterix (QTRX) United States $0.342B 0.00
Cerus (CERS) United States $0.332B 0.00
Viemed Healthcare (VMD) United States $0.317B 30.18
Biote (BTMD) United States $0.306B 6.71
Sanara MedTech (SMTI) United States $0.285B 0.00
OraSure Technologies (OSUR) United States $0.272B 18.25
High Tide (HITI) Canada $0.250B 103.00
Zynex (ZYXI) United States $0.245B 51.20
Canopy Growth (CGC) Canada $0.237B 0.00
Sanuwave Health (SNWV) United States $0.226B 3.18
Aurora Cannabis (ACB) Canada $0.211B 0.00
Utah Medical Products (UTMD) United States $0.211B 14.56
Organigram Holdings (OGI) Canada $0.196B 0.00
Brainsway (BWAY) Israel $0.192B 102.30
MacroGenics (MGNX) United States $0.188B 0.00
TerrAscend (TSNDF) Canada $0.168B 0.00
TriSalus Life Sciences (TLSI) United States $0.150B 0.00
FitLife Brands (FTLF) United States $0.149B 18.77
Veru (VERU) United States $0.143B 0.00
Jin Medical (ZJYL) China $0.143B 0.00
Quipt Home Medical (QIPT) United States $0.130B 0.00
Fonar (FONR) United States $0.096B 10.87
Oramed Pharmaceuticals (ORMP) United States $0.092B 0.00
INLIF (INLF) $0.078B 0.00
InterCure (INCR) Israel $0.077B 0.00
Exagen (XGN) United States $0.070B 0.00
Rockwell Medical (RMTI) United States $0.069B 35.33
Jushi Holdings (JUSHF) United States $0.063B 0.00
Ayr Wellness (AYRWF) United States $0.058B 0.00
Cytosorbents (CTSO) United States $0.056B 0.00
Apyx Medical (APYX) United States $0.052B 0.00
ImmuCell (ICCC) United States $0.049B 0.00
Modular Medical (MODD) United States $0.042B 0.00
Safety Shot (SHOT) United States $0.033B 0.00
Nephros (NEPH) United States $0.017B 0.00
Innovative Eyewear (LUCY) United States $0.014B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Meihua Medical Technologies (MHUA) China $0.008B 0.00
Allurion Technologies (ALUR) United States $0.008B 0.00
Trinity Biotech (TRIB) Ireland $0.006B 0.00
Agape ATP (ATPC) $0.005B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Sharps Technology (STSS) United States $0.004B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
GlucoTrack (GCTK) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 14.11
SNDL (SNDL) Canada $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00